NCT06480890Completed
Real-World Effectiveness of a Triple Combination BDP/FF/GB in a Single Pressurised Metered Dose Inhaler in COPD Patients (TRIPHY)
A 12-Week Single-Cohort Study, to Evaluate Real-World Effectiveness of a Triple Combination Beclometasone Diproprionate/Formoterol Fumarate/Glycopyrronium Bromide (BDP/FF/GB) in a Single Pressurised Metered Dose Inhaler (Trimbow® pMDI) in Subjects With COPD
Source: ClinicalTrials.gov · Last updated 12 Dec 2025
Brief summary (registry, in English)
The purpose of the study is to evaluate Real-World Effectiveness of a Triple Combination Beclometasone Diproprionate/Formoterol Fumarate/Glycopyrronium Bromide (BDP/FF/GB) in a Single Pressurised Metered Dose Inhaler (Trimbow® pMDI) in Subjects with Chronic Obstructive Pulmonary Disease (COPD).
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 362 (actual)
- First submitted
- 12 Jun 2024
- Start date
- 2 Jul 2024
- Primary completion date
- 12 Sept 2025
- Lead sponsor
- Chiesi Farmaceutici S.p.A.
- Diseases
- COPD
- NCT number
- NCT06480890
What you commit to
- Study type: Observational
- Participants enrolled: 362
- From 2 Jul 2024 to the primary completion date, 12 Sept 2025
- 19 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Subjects who had been admitted to hospital for a COPD exacerbation within the last 4 weeks prior to BDP/FF/GB initiation
- Participation in any clinical trial in the 4 weeks prior to BDP/FF/GB initiation
- Subjects had used any other single inhaler triple therapy before or at BDP/FF/GB initiation
Other
- Subjects who are not likely to come back 12-weeks after BDP/FF/GB initiation, per Investigator judgement
Who the study is looking for
- Subjects who are willing and able to give their written consent to participate in the study
- Aged ≥40 years at BDP/FF/GB initiation
- Had documented diagnosis of COPD prior to BDP/FF/GB initiation
- Baseline CAT total score ≥10 (at the time of BDP/FF/GB initiation OR within the 12 weeks prior to treatment initiation, if no CAT total score is available on BDP/FF/GB initiation date)
- Subjects who have initiated treatment with BDP/FF/GB within 12 weeks prior to informed consent form (ICF) signature, or on date of ICF signature
Age in the registry: 40 years to - · Sex: All · Does not accept healthy volunteers
Sites (19)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Site 156110 Beijing Jingmei Group Genetal Hospital Coordinator of this site? Confirm its status | Beijing | China | Unknown status |
| Site 156119 - Peking University People's Hospital Coordinator of this site? Confirm its status | Beijing | China | Unknown status |
| Site 156122 - Deyang People's Hospital Coordinator of this site? Confirm its status | Deyang | China | Unknown status |
| Site 156101 - The First Affiliated Hospital of Guangzhou Medical University Coordinator of this site? Confirm its status | Guangzhou | China | Unknown status |
| Site 156113 - The Second Affiliated Hospital of Guangzhou Medical University Coordinator of this site? Confirm its status | Guangzhou | China | Unknown status |
| Site 156106 - Huzhou Central Hospital Coordinator of this site? Confirm its status | Huzhou | China | Unknown status |
| Site 156109 - Shandong Provincial Hospital Coordinator of this site? Confirm its status | Jinan | China | Unknown status |
| Site 156115 - Jinhua Central Hospital Coordinator of this site? Confirm its status | Jinhua | China | Unknown status |
| Site 156124 - Lishui People's Hospital Coordinator of this site? Confirm its status | Lishui | China | Unknown status |
| Site 156102 - Mianyang Central Hospital Coordinator of this site? Confirm its status | Mianyang | China | Unknown status |
| Site 156125 - Nanjing Drum Tower Hospital Coordinator of this site? Confirm its status | Nanjing | China | Unknown status |
| Site 156112 - The First Affiliated Hospital of Ningbo University Coordinator of this site? Confirm its status | Ningbo | China | Unknown status |
| Site 156103 - Shaoxing People's Hospital Coordinator of this site? Confirm its status | Shaoxing | China | Unknown status |
| Site 156105 - Taizhou Central Hospital Coordinator of this site? Confirm its status | Taizhou | China | Unknown status |
| Site 156121 - The First Affiliated Hospital of Xinjiang Medical University Coordinator of this site? Confirm its status | Ürümqi | China | Unknown status |
| Site 156123 - Wenling People's Hospital Coordinator of this site? Confirm its status | Wenling | China | Unknown status |
| Site 156117 - The Second Affiliated Hospital of Xi'an Jiaotong University Coordinator of this site? Confirm its status | Xi'an | China | Unknown status |
| Site 156114 - The Second Affiliated Hospital of Guangdong Medical University Coordinator of this site? Confirm its status | Zhanjiang | China | Unknown status |
| Site 156108 - Henan Provincial People's Hospital Coordinator of this site? Confirm its status | Zhengzhou | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.